BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 11521190)

  • 1. NF-kappaB/RelA transactivation is required for atypical protein kinase C iota-mediated cell survival.
    Lu Y; Jamieson L; Brasier AR; Fields AP
    Oncogene; 2001 Aug; 20(35):4777-92. PubMed ID: 11521190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of Bcr-Abl-mediated NF-kappaB/Rel activation.
    Kirchner D; Duyster J; Ottmann O; Schmid RM; Bergmann L; Munzert G
    Exp Hematol; 2003 Jun; 31(6):504-11. PubMed ID: 12829026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of a novel Rac/RhoA guanosine triphosphatase-nuclear factor-kappaB inducing kinase signaling pathway mediating angiotensin II-induced RelA transactivation.
    Choudhary S; Lu M; Cui R; Brasier AR
    Mol Endocrinol; 2007 Sep; 21(9):2203-17. PubMed ID: 17595324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear factor-kappaB/IkappaB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells.
    Huang Y; Johnson KR; Norris JS; Fan W
    Cancer Res; 2000 Aug; 60(16):4426-32. PubMed ID: 10969788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of atypical protein kinase C within the nerve growth factor signaling cascade: relationship to differentiation and survival of PC12 cells.
    Wooten MW; Seibenhener ML; Neidigh KB; Vandenplas ML
    Mol Cell Biol; 2000 Jul; 20(13):4494-504. PubMed ID: 10848576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.
    Dong QG; Sclabas GM; Fujioka S; Schmidt C; Peng B; Wu T; Tsao MS; Evans DB; Abbruzzese JL; McDonnell TJ; Chiao PJ
    Oncogene; 2002 Sep; 21(42):6510-9. PubMed ID: 12226754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.
    Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Sonenshein GE
    Cancer Res; 2002 Nov; 62(22):6770-8. PubMed ID: 12438279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation.
    Reuther JY; Reuther GW; Cortez D; Pendergast AM; Baldwin AS
    Genes Dev; 1998 Apr; 12(7):968-81. PubMed ID: 9531535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ectopic expression of protein-tyrosine kinase Bcr-Abl suppresses tumor necrosis factor (TNF)-induced NF-kappa B activation and IkappaBalpha phosphorylation. Relationship with down-regulation of TNF receptors.
    Mukhopadhyay A; Shishodia S; Suttles J; Brittingham K; Lamothe B; Nimmanapalli R; Bhalla KN; Aggarwal BB
    J Biol Chem; 2002 Aug; 277(34):30622-8. PubMed ID: 12060665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase Ciota activity is necessary for Bcr-Abl-mediated resistance to drug-induced apoptosis.
    Jamieson L; Carpenter L; Biden TJ; Fields AP
    J Biol Chem; 1999 Feb; 274(7):3927-30. PubMed ID: 9933579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MEK kinase 1 mediates the antiapoptotic effect of the Bcr-Abl oncogene through NF-kappaB activation.
    Nawata R; Yujiri T; Nakamura Y; Ariyoshi K; Takahashi T; Sato Y; Oka Y; Tanizawa Y
    Oncogene; 2003 Oct; 22(49):7774-80. PubMed ID: 14586403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taxol selectively blocks microtubule dependent NF-kappaB activation by phorbol ester via inhibition of IkappaBalpha phosphorylation and degradation.
    Spencer W; Kwon H; Crépieux P; Leclerc N; Lin R; Hiscott J
    Oncogene; 1999 Jan; 18(2):495-505. PubMed ID: 9927206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-kappaB inducing kinase activates NF-kappaB transcriptional activity independently of IkappaB kinase gamma through a p38 MAPK-dependent RelA phosphorylation pathway.
    Jijon H; Allard B; Jobin C
    Cell Signal; 2004 Sep; 16(9):1023-32. PubMed ID: 15212763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappaB activation.
    Hsu TC; Nair R; Tulsian P; Camalier CE; Hegamyer GA; Young MR; Colburn NH
    Cancer Res; 2001 May; 61(10):4160-8. PubMed ID: 11358840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of airway epithelial cell NF-kappa B-dependent gene expression by protein kinase C delta.
    Page K; Li J; Zhou L; Iasvovskaia S; Corbit KC; Soh JW; Weinstein IB; Brasier AR; Lin A; Hershenson MB
    J Immunol; 2003 Jun; 170(11):5681-9. PubMed ID: 12759450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel-induced immune suppression is associated with NF-kappaB activation via conventional PKC isotypes in lipopolysaccharide-stimulated 70Z/3 pre-B lymphocyte tumor cells.
    Lee M; Jeon YJ
    Mol Pharmacol; 2001 Feb; 59(2):248-53. PubMed ID: 11160860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylshikonin induces apoptosis of human leukemia cell line K562 by inducing S phase cell cycle arrest, modulating ROS accumulation, depleting Bcr-Abl and blocking NF-κB signaling.
    Hao G; Zhai J; Jiang H; Zhang Y; Wu M; Qiu Y; Fan C; Yu L; Bai S; Sun L; Yang Z
    Biomed Pharmacother; 2020 Feb; 122():109677. PubMed ID: 31810012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of atypical PKC in PC12 cells enhances NGF-responsiveness and survival through an NF-kappaB dependent pathway.
    Wooten MW; Seibenhener ML; Zhou G; Vandenplas ML; Tan TH
    Cell Death Differ; 1999 Aug; 6(8):753-64. PubMed ID: 10467349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase C-delta regulates thrombin-induced ICAM-1 gene expression in endothelial cells via activation of p38 mitogen-activated protein kinase.
    Rahman A; Anwar KN; Uddin S; Xu N; Ye RD; Platanias LC; Malik AB
    Mol Cell Biol; 2001 Aug; 21(16):5554-65. PubMed ID: 11463837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsenic inhibits NF-kappaB-mediated gene transcription by blocking IkappaB kinase activity and IkappaBalpha phosphorylation and degradation.
    Roussel RR; Barchowsky A
    Arch Biochem Biophys; 2000 May; 377(1):204-12. PubMed ID: 10775461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.